Comparing Relapse Rates in Real-World Patients with Schizophrenia Who Were Adequately versus Not Adequately Treated with Paliperidone Palmitate Once-Monthly Injections Before Transitioning to Once-Every-3-Months Injections

Comparing Relapse Rates in Real-World Patients with Schizophrenia Who Were Adequately versus Not Adequately Treated with Paliperidone Palmitate Once-Monthly Injections Before Transitioning to Once-Every-3-Months Injections

Ibrahim Turkoz,1 Mehmet Daskiran,1 H Lynn Starr,2 Dean Najarian,2 Oliver Lopena,2 Camilo Obando,2 Alexander Keenan,3 Carmela Benson,3 Srihari Gopal4 1Statistics & Decision Sciences, Janssen Research and Development, LLC, Titusville, NJ, USA; 2Neuroscience, Janssen Scientific Affairs, LLC, Titusv...

Full description

Bibliographic Details
Main Authors: Turkoz I, Daskiran M, Starr HL, Najarian D, Lopena O, Obando C, Keenan A, Benson C, Gopal S
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
paliperidone palmitate
schizophrenia
real-world
relapse
long-acting injectable antipsychotic
Online Access:https://www.dovepress.com/comparing-relapse-rates-in-real-world-patients-with-schizophrenia-who--peer-reviewed-fulltext-article-NDT

Internet

https://www.dovepress.com/comparing-relapse-rates-in-real-world-patients-with-schizophrenia-who--peer-reviewed-fulltext-article-NDT

Similar Items